首页> 外国专利> COMBINATION OF REUPTAKE INHIBITOR OF 5-HT WITH SELECTIVE 5-HT1A ANTAGONIST

COMBINATION OF REUPTAKE INHIBITOR OF 5-HT WITH SELECTIVE 5-HT1A ANTAGONIST

机译:5-HT再摄取抑制剂与选择性5-HT 1A 拮抗剂的组合

摘要

FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention concerns a combination of the first component (a) that is a reuptake inhibitor of 5-HT with the second component (b) that is a selective antagonist of 5-HT1A of the formula (I) where R1 means n-propyl or cyclobutyl; R2 means isopropyl, tert. -butyl, cyclobutyl, cyclopentyl or cyclohexyl; R3 means hydrogen atom; R4 means hydrogen atom or methyl in the form of (R)-enantiomer as a free base or its pharmaceutically acceptable salts. Invention relates to also its synthesis, pharmaceutical preparations containing the indicated combination used for treatment of affective disorders. The described composition is more effective in treatment of affective states. EFFECT: valuable properties of inhibitor, enhanced effectiveness of combination. 19 cl, 1 dwg, 9 ex
机译:领域:有机化学,医学,药学。物质:本发明涉及作为组分的5-HT再摄取抑制剂的第一组分(a)与作为式(5-HT 1A 的选择性拮抗剂的第二组分(b)的组合。 I)<图像文件=“ 00000002.GIF” he =“ 43” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 47” />其中R 1 表示正丙基或环丁基; R 2 表示异丙基,叔。丁基,环丁基,环戊基或环己基; R 3 是指氢原子; R 4 是指(R)-对映体形式的氢原子或甲基,其为游离碱或其药学上可接受的盐。本发明还涉及其合成,药物制剂,其包含用于治疗情感障碍的所示组合。所描述的组合物在治疗情感状态方面更有效。效果:抑制剂的宝贵特性,增强了组合的有效性。 19 cl,1 dwg,9 ex

著录项

  • 公开/公告号RU2183955C2

    专利类型

  • 公开/公告日2002-06-27

    原文格式PDF

  • 申请/专利权人 ASTRAZENEKA AB (SE);

    申请/专利号RU19970119427

  • 申请日1996-04-23

  • 分类号A61K31/352;A61K31/4406;A61P25/24;

  • 国家 RU

  • 入库时间 2022-08-22 00:28:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号